EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries

Ståle Nygård iD, Thea Eline Hetland Falkenthal iD, Tina Sture iD, Elsebeth Lynge, Miriam Elfström, Mari Nygård

The Journal of Infectious Diseases · 17.03.2025 · 231 (3) · e497-e500

DOI: 10.1093/infdis/jiae584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 21.11.2024. Verfasst von Ståle Nygård und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Vaccines, Papillomavirus Infections, Vaccination. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD Norway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Scandinavia, human papillomavirus (HPV) vaccination programs started in 2007–2008 in Sweden and Denmark with HPV vaccination offered to multiple cohorts of young girls, while in Norway this was offered to a single cohort only. Interestingly, in Sweden and Denmark, cervical cancer incidence in young women decreased markedly from 2017 to 2018, while in Norway a steady increase was seen until 2020. As the 3 countries are very similar in other factors important for cervical cancer incidence rates, like cervical cancer screening, the observed difference is most likely due to differences in the multicohort vaccination.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus VaccinesPapillomavirus InfectionsVaccinationHumansFemaleAdultYoung AdultIncidenceScandinavian and Nordic CountriesSwedenNorwayAdolescentDenmarkHuman Papillomavirus Viruses

Stichwörter der Autor:innen

Scandinavian countriescervical cancer incidence rateshuman papillomavirus (HPV)multicohort vaccinationsingle-cohort vaccination

Substanzen

Papillomavirus Vaccines

Autor:innen und Institutionen

  • Department of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.
  • Zealand University Hospital, Nykøbing Falster, Denmark.
  • Center of Cervical Cancer Elimination, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Ståle Nygård, Thea Eline Hetland Falkenthal, Tina Sture

Förderung

  • MSD Norway

Zitieren

APA

Nygård, S., Hetland Falkenthal, T. E., Sture, T., Lynge, E., Elfström, M., & Nygård, M. (2025). Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries. The Journal of Infectious Diseases, 231(3), e497-e500. https://doi.org/10.1093/infdis/jiae584

Vancouver

Nygård S, Hetland Falkenthal TE, Sture T, Lynge E, Elfström M, Nygård M. Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries. The Journal of Infectious Diseases. 2025;231(3):e497-e500. doi:10.1093/infdis/jiae584

BibTeX
@article{Nygrd2025,
  author = {Nygård, Ståle and Hetland Falkenthal, Thea Eline and Sture, Tina and Lynge, Elsebeth and Elfström, Miriam and Nygård, Mari},
  title = {Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {3},
  pages = {e497--e500},
  doi = {10.1093/infdis/jiae584}
}
Kostenlos starten →